CCR5 and metastatic malignant neoplasm in the lymph nodes: In addition, we found that the CCR5+/CD4+ ratio was higher in the axillary lymph node metastasis group (0.23 ± 0.07 vs. 0.16 ± 0.03, P < 0.001) (Figure 8C).